Tonix Pharmaceuticals Holding Corp (TNXP) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Summary

Tonix Pharmaceuticals Holding Corp (Tonix) is a developer of pharmaceutical products to address public health challenges. The company offers pharmaceutical products and treatments for disorders of the central nervous system including fibromyalgia, post traumatic stress disorder and episodic tension-type headache. Its products include oral formulation, smallpox vaccine, disintegrating sublingual tablets and tonmya. Tonixs tonmya is a lead product candidate, designed as a bedtime treatment for post traumatic stress disorder. Its disintegrating sublingual tablets contain a dose and formulation of cyclobenzaprine and is used for the treatment of fibromyalgia and post-traumatic stress disorder. It markets its products through a network of distributors across the US. It has operations in Ireland, Canada and the US. Tonix is headquartered in New York, the US.

Tonix Pharmaceuticals Holding Corp (TNXP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Tonix Pharma Enters into Agreement with U.S. Army Medical Materiel Development Activity 12
Equity Offering 13
Tonix Pharma Plans to Raise up to USD75 Million in Public Offering of Securities 13
Tonix Pharma to Raise up to USD15 Million in Private Placement of Shares 14
Tonix Pharma Plans to Raise up to USD9 Million in Public Offering of Shares 15
Tonix Pharmaceuticals Holding Raises USD8 Million in Public Offering of Shares 16
Tonix Pharma Raises USD5.2 Million in Public Offering of Units 18
Tonix Pharma Raises Funds in Private Placement of Shares 20
Tonix Pharma Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Shares for USD11.5 Million 21
Tonix Pharma Raises USD0.008 Million in Private Placement of Shares up on Exercise of Warrants 23
Tonix Pharma Raises USD20.1 Million in Public Offering of Shares 24
Tonix Pharma Raises USD28.7 Million in Public Offering of Shares 26
Tonix Pharma Raises USD0.12 Million in Private Placement of Shares up on Exercise of Warrants 28
Tonix Pharma Raises USD0.01 Million in Private Placement of Shares up on Exercise of Warrants 29
Tonix Pharma Raises USD0.16 Million in Private Placement of Shares up on Exercise of Warrants 30
Tonix Pharma Raises USD0.04 Million in Private Placement of Shares up on Exercise of Warrants 31
Tonix Pharma Raises USD0.02 Million in Private Placement of Shares up on Exercise of Warrants 32
Tonix Pharma Raises USD0.13 Million in Private Placement of Shares up on Exercise of Warrants 33
Tonix Pharma Raises USD0.006 Million in Private Placement of Shares up on Exercise of Warrants 34
Tonix Pharma Raises USD0.04 Million in Private Placement of Shares up on Exercise of Warrants 35
Tonix Pharma to Raise USD8 Million in Private Placement of Shares 36
Tonix Pharma Completes Public Offering Of Shares For US$43.5 Million 38
Tonix Pharma Completes Public Offering Of Units For US$11.4 Million 40
Tonix Pharma Completes Second Tranche Of Private Placement Of Units For US$1 Million 42
Tonix Pharma Completes Second Tranche Of Private Placement Of Units For US$2.3 Million 44
Debt Offering 45
Tonix Pharmaceuticals Completes Private Placement Of Notes Due 2013 For US$1 Million 45
Tonix Pharmaceuticals Holding Corp - Key Competitors 46
Tonix Pharmaceuticals Holding Corp - Key Employees 47
Tonix Pharmaceuticals Holding Corp - Locations And Subsidiaries 48
Head Office 48
Other Locations & Subsidiaries 48
Recent Developments 49
Financial Announcements 49
May 14, 2018: Tonix Pharmaceuticals Announces First Quarter 2018 Financial Results 49
Mar 12, 2018: Tonix Pharmaceuticals Announces Fourth Quarter and Full Year 2017 Financial Results 50
Nov 07, 2017: Tonix Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Programs Update 52
Aug 14, 2017: Tonix Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Programs Update 54
Apr 17, 2017: Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Programs Update 56
Corporate Communications 58
Feb 15, 2018: Tonix Pharmaceuticals Appoints David L. Grange to the Board of Directors 58
Jan 09, 2018: Tonix Pharmaceuticals Appoints Jessica Morris as Chief Operating Officer 59
Product News 60
01/10/2017: Tonix Pharmaceuticals Provides Update on TNX-601 at 9th Annual Biotech Showcase Conference 60
Appendix 61
Methodology 61
About GlobalData 61
Contact Us 61
Disclaimer 61

List Of Tables

List of Tables
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Tonix Pharmaceuticals Holding Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Tonix Pharma Enters into Agreement with U.S. Army Medical Materiel Development Activity 12
Tonix Pharma Plans to Raise up to USD75 Million in Public Offering of Securities 13
Tonix Pharma to Raise up to USD15 Million in Private Placement of Shares 14
Tonix Pharma Plans to Raise up to USD9 Million in Public Offering of Shares 15
Tonix Pharmaceuticals Holding Raises USD8 Million in Public Offering of Shares 16
Tonix Pharma Raises USD5.2 Million in Public Offering of Units 18
Tonix Pharma Raises Funds in Private Placement of Shares 20
Tonix Pharma Completes Underwriters Exercise of Over-Allotment Option of Public Offering of Shares for USD11.5 Million 21
Tonix Pharma Raises USD0.008 Million in Private Placement of Shares up on Exercise of Warrants 23
Tonix Pharma Raises USD20.1 Million in Public Offering of Shares 24
Tonix Pharma Raises USD28.7 Million in Public Offering of Shares 26
Tonix Pharma Raises USD0.12 Million in Private Placement of Shares up on Exercise of Warrants 28
Tonix Pharma Raises USD0.01 Million in Private Placement of Shares up on Exercise of Warrants 29
Tonix Pharma Raises USD0.16 Million in Private Placement of Shares up on Exercise of Warrants 30
Tonix Pharma Raises USD0.04 Million in Private Placement of Shares up on Exercise of Warrants 31
Tonix Pharma Raises USD0.02 Million in Private Placement of Shares up on Exercise of Warrants 32
Tonix Pharma Raises USD0.13 Million in Private Placement of Shares up on Exercise of Warrants 33
Tonix Pharma Raises USD0.006 Million in Private Placement of Shares up on Exercise of Warrants 34
Tonix Pharma Raises USD0.04 Million in Private Placement of Shares up on Exercise of Warrants 35
Tonix Pharma to Raise USD8 Million in Private Placement of Shares 36
Tonix Pharma Completes Public Offering Of Shares For US$43.5 Million 38
Tonix Pharma Completes Public Offering Of Units For US$11.4 Million 40
Tonix Pharma Completes Second Tranche Of Private Placement Of Units For US$1 Million 42
Tonix Pharma Completes Second Tranche Of Private Placement Of Units For US$2.3 Million 44
Tonix Pharmaceuticals Completes Private Placement Of Notes Due 2013 For US$1 Million 45
Tonix Pharmaceuticals Holding Corp, Key Competitors 46
Tonix Pharmaceuticals Holding Corp, Key Employees 47
Tonix Pharmaceuticals Holding Corp, Other Locations 48
Tonix Pharmaceuticals Holding Corp, Subsidiaries 48

List Of Figures

List of Figures
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Tonix Pharmaceuticals Holding Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Tonix Pharmaceuticals Holding Corp (TNXP) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Tonix Pharmaceuticals Holding Corp (Tonix) is a developer of pharmaceutical products to address public health challenges. The company offers pharmaceutical products and treatments for disorders of the central nervous system

USD 250 View Report

Tonix Pharmaceuticals Holding Corp Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

Tonix Pharmaceuticals Holding Corp Company Profile is a detailed strategic and analytical report on Tonix Pharmaceuticals Holding Corp. The 2018 version of the report offers detailed insights into the companys

USD 200 View Report

Adgero Biopharmaceuticals Holdings Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Adgero Biopharmaceuticals Holdings Inc (Adgero), formerly Adgero Biopharmaceuticals Inc is a biopharmaceutical company that develops proprietary late stage photodynamic therapy platform for the treatment of oncology indications. The companys pipeline

USD 250 View Report

Santhera Pharmaceuticals Holding AG - Mergers and Acquisitions (MandA), Partnerships and Alliances and Investment Report

Santhera Pharmaceuticals Holding AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment ReportThe Santhera Pharmaceuticals Holding AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes

USD 350 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available